Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Geographic atrophy secondary to age-related macular degeneration
Economic impact of diagnostic testing
4 evidence topics · 4 sources
Medicare national average office-based payment for retinal imaging, 2025 and 2026
| CPT code | 2025 non-facility total RVUs | 2026 non-facility total RVUs | 2025 non-facility pay | 2026 non-facility pay | Change in non-facility pay, 2025 to 2026 |
|---|---|---|---|---|---|
| 92134 (OCT, retina) | “0.97” | “0.98” | “$31.38” | “$32.73” | “4.32%” |
| 92137 (OCT angiography, retina) | “1.76” | “1.79” | “$56.93” | “$59.79” | “5.02%” |
| 92250 (fundus photography) | “1.1” | “1.11” | “$35.58” | “$37.07” | “4.20%” |
| 92235 (fluorescein angiography) | “4.72” | “4.86” | “$152.68” | “$162.33” | “6.32%” |
Coding of multimodal imaging for geographic atrophy
Diagnostic imaging at the index diagnosis: Medicare Advantage claims
| Diagnostic procedure received on index date | Participants with GA, n (%) |
|---|---|
| Any of the procedures below | “6,968 (73.3)”View highlighted excerpt for this quote |
| OCT | “5,042 (53.0)”View highlighted excerpt for this quote |
| Fundus photography | “2,039 (21.4)”View highlighted excerpt for this quote |
| Fluorescein angiography | “600 (6.3)”View highlighted excerpt for this quote |
| Fluorescein and indocyanine-green angiography at the same time | “97 (1.0)”View highlighted excerpt for this quote |
“The specialty of the GA diagnosing provider was determined using National Provider Identifiers, and diagnostic imaging procedures used for confirming GA diagnosis were identified using Current Procedural Terminology codes” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Among individuals with GA, initial diagnosis was primarily by an ophthalmologist (58.6%) followed by an optometrist (30.9%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Diagnostic tests as the main driver of direct ophthalmic costs
“A variety of tests were conducted at GA diagnosis; the most common ones (used in the 98 patients initially diagnosed with bilateral GA) were distance VA (86.7%), dilated eye examination (82.7%), optical coherence tomography (OCT; 81.6%), intraocular pressure (IOP; 67.3%), and fundus autofluorescence (FAF; 44.9%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Similar to the UK cohort study, direct HCRU in our study accounted for the majority of the mean annual total costs (88%; €1772), with diagnostics tests and procedures being the main driver (€1071 per patient).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote